Autism
Gene: PRODH
Association between biallelic variants and biochemical phenotype of hyperprolinaemia type 1 (HP1) is established, however, association with neurodevelopmental disorders (ID, autism, epilepsy) has not been established.
ClinGen Aminoacidopathy GCEP note biallelic pathogenic variants have been reported in both asymptomatic individuals and those with neurodevelopmental disorders but mention a likely benign clinical course for HP1. Most of the literature identifying PRODH variants in individuals with neurodevelopmental issues/epilepsy and HP1 are older publications and these individuals did not have current standard of care WES/WGS testing, only targeted testing for PRODH. Whilst the PRODH variants may explain the HP1, it is possible that there is an alternative monogenic cause for the other phenotypic features. In addition, some of the reported variants have a very high gnomAD frequency. Of note, a number of LoF variants are filtered out in gnomAD due to a neighbouring pseudogene, so there is potential for the true population frequency being even higher.
Downgrading gene to Amber for association with ID, autism and epilepsy to reflect this uncertainty.Created: 14 Feb 2026, 5:18 p.m. | Last Modified: 14 Feb 2026, 5:18 p.m.
Panel Version: 0.244
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
hyperprolinemia type 1 - MONDO:0009400
Publications
Phenotypes for gene: PRODH were changed from to hyperprolinemia type 1 - MONDO:0009400
Mode of inheritance for gene: PRODH was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
Gene: prodh has been classified as Amber List (Moderate Evidence).
Gene: prodh has been classified as Green List (High Evidence).
gene: PRODH was added gene: PRODH was added to Autism_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: PRODH was set to Unknown